Your SVS: Executive Board sets course for year

2852
SVS President Joseph Mills

Phase II of a national branding campaign for vascular surgery and three new task forces are just two of several initiatives the SVS’ Executive Board highlighted for further action during its recent board retreat.

The SVS Strategic Board meets each January to review the Society’s strategic plan and develop priorities for the coming year. Each July, the Executive Board meets to accelerate implementation of those key priorities that were identified by the Strategic Board. The Executive Board met July 27–29 under the leadership of SVS President Joseph Mills, MD, and took action to move multiple priorities forward:

  • Granted approval for and agreed to provide resources for phase II of a major national branding campaign for vascular surgery
  • Established a Bylaws Subcommittee to deliberate, carefully consider and recommend any further changes regarding selection and election of SVS officers and Executive Board members
  • Established three new task forces to fast-track development: a Research Clinical Trials (RCT) Task Force to foster and accelerate new trials; an Innovation Task Force to provide education and resources to help member entrepreneurs; and a Patient Engagement Task Force to optimize patient engagement in the work of the SVS
  • Agreed to develop a new, dedicated Advocacy/Health Policy Leadership Conference
  • Approved methodology and terminology to move forward with appropriate use criteria (AUC) for management of carotid artery occlusive disease
  • Established a private practice peer review process to augment the upcoming launch of the Vascular Verification Outpatient Program

The board will continue to keep members informed across SVS communication channels, including Pulse, Vascular Specialist, social media, SVSConnect and email, and will seek volunteers to contribute to these efforts.

“The Strategic Board was preceded by a half-day meeting of major stakeholders to consider the status and progress of diversity, equity and inclusion within the SVS,” said Mills.

“Branding, advocacy, appropriate use and outpatient peer review represent just a few of the key topics we discussed and the paths forward that we initiated. We will keep members informed and engaged as we move forward, seeking feedback, contributions and broad participation from our SVS membership.”

LEAVE A REPLY

Please enter your comment!
Please enter your name here